2785404-76-2

2785404-76-2 structure

Name: PROTAC HDAC6 degrader 1
Chemical Name: PROTAC HDAC6 degrader 1
CAS Number: 2785404-76-2
Molecular Formula: C₃₇H₄₆N₆O₁₀
Molecular Weight: 734.80
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2023-02-01 11:23:24
Modify Date: 2024-04-06 01:00:02
PROTAC HDAC6 degrader (Compound A6) is a potent and selective PROTAC HDAC6 degrader with a DC50 of 3.5 nM. PROTAC HDAC6 degrader shows promising antiproliferative activity via inducing apoptosis in myeloid leukemia cell lines[1].

Name	PROTAC HDAC6 degrader 1

Description	PROTAC HDAC6 degrader (Compound A6) is a potent and selective PROTAC HDAC6 degrader with a DC50 of 3.5 nM. PROTAC HDAC6 degrader shows promising antiproliferative activity via inducing apoptosis in myeloid leukemia cell lines[1].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Signaling Pathways >> PROTAC >> PROTAC Signaling Pathways >> Cell Cycle/DNA Damage >> HDAC Signaling Pathways >> Epigenetics >> HDAC
Target	HDAC6:3.5 nM (DC50) HDAC6:4.86 nM (IC50) HDAC1:0.1 μM (IC50)
In Vitro	PROTAC HDAC6 degrader (Compound A6) (0.1-10 μM; 6 h) does not degrade HDAC1 but displays inhibitory activity toward HDAC1. PROTAC HDAC6 degrader demonstrates potent HDAC6 degradation as well as hyperacetylation of α-tubulin in U266 and HL-60 cells, confirming that the activity is not restricted to leukemia cell lines[1]. PROTAC HDAC6 degrader (0.5-50 μM) inhibits leukemia cells viability with log IC50 values of 1.2-1.7 μM[1]. PROTAC HDAC6 degrader (8-24 μM; 48 h) induces MOLM13 cell apoptosis and arrests cell cycle at sub-G1 phase[1]. Western Blot Analysis[1] Cell Line: HL-60 cells Concentration: 100 nM, 1 μM, 10 μM Incubation Time: 6 h Result: Degraded HDAC6 but not HDAC1. Induced hyperacetylation of α-tubulin and caused hyperacetylation of histone H3. Cell Viability Assay[1] Cell Line: Acute myeloid leukemia or AML (HL-60, Kasumi, THP-1, HL-60, SKNO1, and MOLM13) and B-cell acute lymphoblastic leukemia or B-ALL (REH and 697) Concentration: 0.5-50 μM Incubation Time: 72 h Result: Inhibited cell viability with log IC50 values of 1.2-1.7 μM. Apoptosis Analysis[1] Cell Line: MOLM13 Concentration: 8, 16 and 24 μM Incubation Time: 48 h Result: Induced caspase 3/7-dependent apoptosis in dose-dependent fashion. Cell Cycle Analysis[1] Cell Line: MOLM13 Concentration: 8, 16 and 24 μM Incubation Time: 48 h Result: Induced a dose-dependent increase in the sub-G1 fraction with a concomitant reduction of cell population in G2/M phase.
References	[1]. Sinatra L, et al. Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity. J Med Chem. 2022 Dec 22;65(24):16860-16878.

Molecular Formula	C₃₇H₄₆N₆O₁₀
Molecular Weight	734.80

2785404-76-2	2439058-23-6
2093386-22-0	2098487-75-1
2097971-01-0	2417369-94-7
2458170-54-0	2301916-69-6
2249944-98-5	2306388-84-9